Related Experiment Video
Updated: Apr 4, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.5K
Pharmacist-provided diabetes management and education via a telemonitoring program
Journal of the American Pharmacists Association : Japha
|September 12, 2015
Summary
Pharmacist-led telemonitoring significantly improved glycosylated hemoglobin (A1C) in patients with diabetes at community health centers. This approach enhances chronic disease management and patient outcomes.
Area of Science:
- Clinical Pharmacy
- Digital Health
- Chronic Disease Management
Background:
- Diabetes management requires continuous monitoring and patient engagement.
- Telemonitoring devices offer a potential solution to expand and improve chronic disease care.
- Underserved populations in community health centers face unique challenges in managing diabetes.
Purpose of the Study:
- To evaluate the impact of pharmacist-led telemonitoring on clinical outcomes in patients with diabetes.
- To assess improvements in glycosylated hemoglobin (A1C), blood pressure, and lipid levels.
- To measure changes in patient knowledge, adherence, and self-efficacy in managing their condition.
Main Methods:
- A comparative study involving 150 patients across four community health centers in Utah.
- Pharmacist-led diabetes management using telemonitoring versus usual care.
- Daily monitoring of blood glucose and blood pressure, with pharmacist follow-up for out-of-range values.
Main Results:
- The telemonitoring group showed a significantly greater reduction in A1C (2.07%) compared to usual care (0.66%; P <0.001).
- While blood pressure and LDL levels decreased, the differences between groups were not statistically significant.
- Patient activation, diabetes/hypertension knowledge, and adherence to antihypertensives improved in the telemonitoring group.
Conclusions:
- Pharmacist-led telemonitoring effectively improved A1C levels in federally qualified community health centers.
- Telemonitoring represents a viable model for delivering clinical pharmacy services to diabetic patients.
- This intervention shows promise for enhancing chronic disease management in underserved populations.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Therapeutic Drug Monitoring: Overview and Classification
523
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
523
Therapeutic Drug Monitoring: Affecting Factors
335
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
335
Diabetes Mellitus: Type 2 and Gestational
5.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.6K
Diabetes Mellitus: Overview and Type I Subtype
6.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.0K
Peripheral Artery Disease III: Interprofessional Care
583
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
583

